Policy | March 31, 2021
Our collective decisions will shape the future policy for equitable distribution of vaccine: Dr. Harsh Vardhan
India produces 60% of the world’s vaccine
India produces 60% of the world’s vaccine
The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.
The vaccine was 85 percent effective in preventing severe disease across all regions.
Union Health Minister highlights India’s progress in universal health coverage, digital health, AI strategy and global vaccine cooperation during plenary session in Geneva
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
The private funding rose 38% amid growing international collaborations and CDMO demand
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
Subscribe To Our Newsletter & Stay Updated
